BIOTRONIK Conduction System Pacing With the Solia Lead

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 194 participants.

Also called NCT05251363

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 194 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05251363
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05251363. Allocation not applicable; no masking; primary purpose treatment. Start 2022-12-12 (actual); primary completion 2024-01-09 (actual). Results posted on 2025-03-18.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
BIOTRONIK Conduction System Pacing With the Solia Lead
Acronym
BIO-CONDUCT
Condition
Bradycardia
Condition
Atrioventricular Block
Condition
Left Bundle-Branch Block
Condition
Cardiomyopathies
Intervention (Device)
Solia S lead
Lead sponsor
Biotronik, Inc. (class: industry)

Record details

Record id
cardio:ct-nct05251363
Content hash
e591a6eb7814a41c5c45cd0f273528abffb840b4c36a2d05eece6b5540bdaf84